SCHEMBL810597

SCHEMBL810597

Cc1ccc(Cc2ccccc2)c(N)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 1/20 0.47
CYP3A4 P08684 2/20 0.46
CYP2D6 P10635 1/20 0.46
TSHR P16473 1/20 0.46
CYP2C19 P33261 1/20 0.46
TDP1 Q9NUW8 2/20 0.45
ALOX15 P16050 2/20 0.45
TP53 P04637 1/20 0.45
THRB P10828 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
BCL2 P10415 1/20 0.44
BCL2L1 Q07817 1/20 0.44
ALDH1A1 P00352 2/20 0.43
ALOX5 P09917 1/20 0.43
SLC6A2 P23975 1/20 0.42
SLC6A4 P31645 1/20 0.42
SLC6A3 Q01959 1/20 0.42
HTR2A P28223 1/20 0.41
CALM1 P0DP23 1/20 0.41
HSD17B10 Q99714 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10562423 0.90 CYP3A4 (0.50) CYP3A4CYP2D6TSHRCYP2C19TDP1
SCHEMBL21509895 0.85 CYP3A4 (0.48) CYP3A4CYP2D6TSHRCYP2C19TDP1
SCHEMBL9657678 0.85 CYP3A4 (0.46) HDAC6CYP3A4CYP2D6TSHRCYP2C19
SCHEMBL9630969 0.84 SLC6A4 (0.53) HDAC6CYP3A4TDP1ALOX15TP53
SCHEMBL29617187 0.83 ALOX15 (0.56) CYP3A4TSHRTDP1ALOX15TP53
SCHEMBL4001757 0.83 ALOX15 (0.56) CYP3A4TSHRTDP1ALOX15TP53
SCHEMBL10509183 0.82 SLC6A4 (0.47) CYP3A4TDP1ALOX15TP53THRB
SCHEMBL4442750 0.82 BCL2 (0.54) CYP3A4CYP2D6TSHRCYP2C19ALOX15
SCHEMBL22897871 0.81 SLC6A2 (0.48) CYP3A4TDP1ALOX15TP53THRB
SCHEMBL22897738 0.81 ACHE (0.46) SLC6A2SLC6A4SLC6A3IDH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114072000-A Molecules having certain pesticidal effects and intermediates, compositions and methods related thereto 科迪华农业科技有限责任公司 2022-02-18 CN disclosed
WO-2021011722-A1 MOLECULES HAVING CERTAIN PESTICIDAL UTILITIES, AND INTERMEDIATES, COMPOSITIONS, AND PROCESSES RELATED THERETO DOW AGROSCIENCES LLC (US) 2021-01-21 WO disclosed
EP-1971611-B1 ANTI-VIRAL COMPOUNDS ABBOTT LAB (US) 2012-10-10 EP disclosed
EP-2345652-A1 Antiviral compounds Abbott Laboratories (US) 2011-07-20 EP disclosed
US-7915411-B2 Anti-viral compounds ABBOTT LABORATORIES (US) 2011-03-29 US disclosed
CN-101443334-A Anti-viral compounds ABBOTT LAB (US) 2009-05-27 CN disclosed
US-20070197558-A1 ANTI-VIRAL COMPOUNDS ABBVIE INC. 2007-08-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070197558-A1 ANTI-VIRAL COMPOUNDS HAVCR2, MAVS, EIF2AK2 HDAC6 55/4885CYP3A4 273/4885CYP2D6 783/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.